These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11303953)
41. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers. Bentz J; Ellens H Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715 [TBL] [Abstract][Full Text] [Related]
42. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. Hilgendorf C; Spahn-Langguth H; RegÄrdh CG; Lipka E; Amidon GL; Langguth P J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539 [TBL] [Abstract][Full Text] [Related]
43. Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers. Lee K; Ng C; Brouwer KL; Thakker DR J Pharmacol Exp Ther; 2002 Nov; 303(2):574-80. PubMed ID: 12388638 [TBL] [Abstract][Full Text] [Related]
44. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Zhang S; Morris ME Pharm Res; 2003 Aug; 20(8):1184-91. PubMed ID: 12948016 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Liang E; Proudfoot J; Yazdanian M Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220 [TBL] [Abstract][Full Text] [Related]
46. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells. Balimane PV; Chong S; Patel K; Quan Y; Timoszyk J; Han YH; Wang B; Vig B; Faria TN Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369 [TBL] [Abstract][Full Text] [Related]
47. Soybean Oil-Based Lipid Emulsion Increases Intestinal Permeability of Lipopolysaccharide in Caco-2 Cells by Downregulation of P-Glycoprotein via ERK-FOXO 3a Pathway. Yan JK; Zhu J; Gu BL; Yan WH; Xiao YT; Zhou KJ; Wen J; Wang Y; Cai W Cell Physiol Biochem; 2016; 39(4):1581-94. PubMed ID: 27627102 [TBL] [Abstract][Full Text] [Related]
48. A structural model for the mass action kinetic analysis of P-gp mediated transport through confluent cell monolayers. Bentz J; Ellens H Methods Mol Biol; 2014; 1113():289-316. PubMed ID: 24523118 [TBL] [Abstract][Full Text] [Related]
49. A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans. Chiou WL; Chung SM; Wu TC; Ma C Int J Clin Pharmacol Ther; 2001 Mar; 39(3):93-101. PubMed ID: 11396754 [TBL] [Abstract][Full Text] [Related]
50. Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters. Cholkar K; Trinh HM; Vadlapudi AD; Wang Z; Pal D; Mitra AK J Ocul Pharmacol Ther; 2015 May; 31(4):248-55. PubMed ID: 25844889 [TBL] [Abstract][Full Text] [Related]
51. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers. Meng Z; Le Marchand S; Agnani D; Szapacs M; Ellens H; Bentz J Drug Metab Dispos; 2017 Feb; 45(2):145-151. PubMed ID: 27856525 [TBL] [Abstract][Full Text] [Related]
52. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Batrakova EV; Li S; Miller DW; Kabanov AV Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651 [TBL] [Abstract][Full Text] [Related]
53. Calculation of an Apical Efflux Ratio from P-Glycoprotein (P-gp) In Vitro Transport Experiments Shows an Improved Correlation with In Vivo Cerebrospinal Fluid Measurements in Rats: Impact on P-gp Screening and Compound Optimization. Fischer H; Senn C; Ullah M; Cantrill C; Schuler F; Yu L J Pharmacol Exp Ther; 2021 Mar; 376(3):322-329. PubMed ID: 33288523 [TBL] [Abstract][Full Text] [Related]
54. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells. Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687 [TBL] [Abstract][Full Text] [Related]
55. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies. Agarwal S; Jain R; Pal D; Mitra AK Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248 [TBL] [Abstract][Full Text] [Related]
56. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. Mease K; Sane R; Podila L; Taub ME J Pharm Sci; 2012 May; 101(5):1888-97. PubMed ID: 22359351 [TBL] [Abstract][Full Text] [Related]
57. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells. Bourdet DL; Pollack GM; Thakker DR Pharm Res; 2006 Jun; 23(6):1178-87. PubMed ID: 16741656 [TBL] [Abstract][Full Text] [Related]
58. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. Troutman MD; Thakker DR Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017 [TBL] [Abstract][Full Text] [Related]
59. Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment. Igarashi F; Nakagawa T; Shinohara Y; Tachibana T Pharm Res; 2021 Jun; 38(6):1031-1039. PubMed ID: 34009624 [TBL] [Abstract][Full Text] [Related]